Adoptive tumour immunotherapy using human CD4+ T-cells.
作者信息
Gold J E, Osband M E
出版信息
Br J Cancer. 1993 Apr;67(4):865-7. doi: 10.1038/bjc.1993.159.
Abstract
摘要
相似文献
1
Adoptive tumour immunotherapy using human CD4+ T-cells.
Br J Cancer. 1993 Apr;67(4):865-7. doi: 10.1038/bjc.1993.159.
2
This month in APR.
Arch Pharm Res. 2010 Nov;33(11):1699-701. doi: 10.1007/s12272-010-1100-x.
3
Density of tumour stroma is correlated to outcome after adoptive transfer of CD4+ and CD8+ T cells in a murine mammary carcinoma model.
Breast Cancer Res Treat. 2010 Jun;121(3):753-63. doi: 10.1007/s10549-009-0559-y. Epub 2009 Sep 30.
4
Is secretion of tumour-specific antigen important for cancer eradication by CD4(+) T cells?--Implications for cancer immunotherapy by adoptive T cell transfer.
Scand J Immunol. 2011 Jun;73(6):527-30. doi: 10.1111/j.1365-3083.2011.02558.x.
5
Adoptive transfer of virus-directed T cells: will this fly for flu?
Cytotherapy. 2012 Feb;14(2):133-4. doi: 10.3109/14653249.2011.644038. Epub 2011 Dec 9.
6
A critical role for neutralizing-antibody-producing B cells, CD4(+) T cells, and interferons in persistent and acute infections of mice with lymphocytic choriomeningitis virus: implications for adoptive immunotherapy of virus carriers.
Proc Natl Acad Sci U S A. 1997 Jun 24;94(13):6874-9. doi: 10.1073/pnas.94.13.6874.
7
Large-scale culture system of human CD4+ helper/killer T cells for the application to adoptive tumour immunotherapy.
Br J Cancer. 1992 Jul;66(1):20-6. doi: 10.1038/bjc.1992.210.
8
CD4+ T cells in adoptive immunotherapy and the indirect mechanism of tumor rejection.
Crit Rev Immunol. 2000;20(1):17-56.
9
Tumor-specific CD4+ T lymphocytes from cancer patients are required for optimal induction of cytotoxic T cells against the autologous tumor.
J Immunol. 2000 Apr 1;164(7):3902-12. doi: 10.4049/jimmunol.164.7.3902.
10
Co-ordinated isolation of CD8(+) and CD4(+) T cells recognizing a broad repertoire of cytomegalovirus pp65 and IE1 epitopes for highly specific adoptive immunotherapy.
Cytotherapy. 2010 Nov;12(7):933-44. doi: 10.3109/14653240903505822.
本文引用的文献
1
Effect of autolymphocyte therapy on survival and quality of life in patients with metastatic renal-cell carcinoma.
Lancet. 1990 Apr 28;335(8696):994-8. doi: 10.1016/0140-6736(90)91064-h.
2
Purified human T cells stimulated with cross-linked anti-CD3 monoclonal antibody OKT3: rIL-1 is a co-stimulatory factor for CD4+CD29+CD45RA- T cells.
Scand J Immunol. 1990 Oct;32(4):359-71. doi: 10.1111/j.1365-3083.1990.tb02930.x.
3
Large-scale culture system of human CD4+ helper/killer T cells for the application to adoptive tumour immunotherapy.
Br J Cancer. 1992 Jul;66(1):20-6. doi: 10.1038/bjc.1992.210.
Zotero 插件